» Articles » PMID: 28709441

Mortality Outcomes of Low-dose Computed Tomography Screening for Lung Cancer in Urban China: a Decision Analysis and Implications for Practice

Overview
Journal Chin J Cancer
Publisher Biomed Central
Specialty Oncology
Date 2017 Jul 16
PMID 28709441
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mortality outcomes in trials of low-dose computed tomography (CT) screening for lung cancer are inconsistent. This study aimed to evaluate whether CT screening in urban areas of China could reduce lung cancer mortality and to investigate the factors that associate with the screening effect.

Methods: A decision tree model with three scenarios (low-dose CT screening, chest X-ray screening, and no screening) was developed to compare screening results in a simulated Chinese urban cohort (100,000 smokers aged 45-80 years). Data of participant characteristics were obtained from national registries and epidemiological surveys for estimating lung cancer prevalence. The selection of other tree variables such as sensitivities and specificities of low-dose CT and chest X-ray screening were based on literature research. Differences in lung cancer mortality (primary outcome), false diagnoses, and deaths due to false diagnosis were calculated. Sensitivity analyses were performed to identify the factors that associate with the screening results and to ascertain worst and optimal screening effects considering possible ranges of the variables.

Results: Among the 100,000 subjects, there were 448, 541, and 591 lung cancer deaths in the low-dose CT, chest X-ray, and no screening scenarios, respectively (17.2% reduction in low-dose CT screening over chest X-ray screening and 24.2% over no screening). The costs of the two screening scenarios were 9387 and 2497 false diagnoses and 7 and 2 deaths due to false diagnosis among the 100,000 persons, respectively. The factors that most influenced death reduction with low-dose CT screening over no screening were lung cancer prevalence in the screened cohort, low-dose CT sensitivity, and proportion of early-stage cancers among low-dose CT detected lung cancers. Considering all possibilities, reduction in deaths (relative numbers) with low-dose CT screening in the worst and optimal cases were 16 (5.4%) and 288 (40.2%) over no screening, respectively.

Conclusions: In terms of mortality outcomes, our findings favor conducting low-dose CT screening in urban China. However, approaches to reducing false diagnoses and optimizing important screening conditions such as enrollment criteria for screening are highly needed.

Citing Articles

Non‑diagnostic electromagnetic navigation bronchoscopy biopsy: Predictive factors and final diagnoses.

Yu W, Ma H, Yu G, Xia P, An Z, Yu L Oncol Lett. 2023; 25(4):166.

PMID: 36960189 PMC: 10028222. DOI: 10.3892/ol.2023.13751.


Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study.

Wang L, Wang Y, Wang F, Gao Y, Fang Z, Gong W JMIR Public Health Surveill. 2023; 9:e43586.

PMID: 36917151 PMC: 10131892. DOI: 10.2196/43586.


A multidimensional model incorporating radiomics score and liquid biopsy for the prediction of malignant and benign pulmonary nodules.

Xu L, Zhou J, Wang L, Yang R, Li T, Zhu X Transl Cancer Res. 2022; 11(11):4009-4018.

PMID: 36523317 PMC: 9745355. DOI: 10.21037/tcr-22-1755.


Implementation planning for lung cancer screening in China.

Cheng Y, Davies M, Liu D, Li W, Field J Precis Clin Med. 2022; 2(1):13-44.

PMID: 35694700 PMC: 8985785. DOI: 10.1093/pcmedi/pbz002.


Advances in lung cancer screening and early detection.

Li C, Wang H, Jiang Y, Fu W, Liu X, Zhong R Cancer Biol Med. 2022; .

PMID: 35535966 PMC: 9196057. DOI: 10.20892/j.issn.2095-3941.2021.0690.


References
1.
Wang S, Wang Z . EGFR mutations in patients with non-small cell lung cancer from mainland China and their relationships with clinicopathological features: a meta-analysis. Int J Clin Exp Med. 2014; 7(8):1967-78. PMC: 4161537. View

2.
Heuvelmans M, Oudkerk M, de Bock G, de Koning H, Xie X, van Ooijen P . Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol. 2013; 23(7):1836-45. DOI: 10.1007/s00330-013-2799-9. View

3.
Zhou Q, Fan Y, Bu H, Wang Y, Wu N, Huang Y . China national lung cancer screening guideline with low-dose computed tomography (2015 version). Thorac Cancer. 2015; 6(6):812-8. PMC: 4632939. DOI: 10.1111/1759-7714.12287. View

4.
Yang J, Zhang X, Su J, Xu C, Zhou Q, Tian H . Lung cancers with concomitant EGFR mutations and ALK rearrangements: diverse responses to EGFR-TKI and crizotinib in relation to diverse receptors phosphorylation. Clin Cancer Res. 2014; 20(5):1383-92. DOI: 10.1158/1078-0432.CCR-13-0699. View

5.
Nawa T, Nakagawa T, Mizoue T, Kusano S, Chonan T, Hayashihara K . A decrease in lung cancer mortality following the introduction of low-dose chest CT screening in Hitachi, Japan. Lung Cancer. 2012; 78(3):225-8. DOI: 10.1016/j.lungcan.2012.09.012. View